SFX by Ex Libris Inc.

Title:	Identification of ZNF313 / RNF114 as a novel psoriasis susceptibility gene
Source:	Human Molecular Genetics [0964-6906] Capon, Francesca yr:2008

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Liu, Y. "A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci." PLoS Genetics 4.4 (2008).
description	2.	Nair, RP P. "Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappa B pathways." Nature genetics 41.2 (2009): 199-204.
description	3.	Gorlova, O. "Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy." PLOS Genetics 7.7 (2011): 1-11.
description	4.	Liu, Y. "Psoriasis: genetic associations and immune system changes." Genes and immunity 8.1 (2007): 1-12.
description	5.	Liu, Jian-Jun J. "Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21." Nature genetics 41.2 (2009): 205-10.
description	6.	Martinsson, T. "A genome-wide search for genes predisposing to familial psoriasis by using a stratification approach." Human genetics 105.6 (1999): 523-529.
description	7.	Martinez-Borra, J. "The Region of 150 kb Telomeric to HLA-C Is Associated with Psoriasis in the Jewish Population." The Journal of investigative dermatology 125.5 (2005): 928-932.
description	8.	Slotman, M. "Evidence for subdivision within the M molecular form of Anopheles gambiae." Molecular ecology 16.3 (2007): 639-649.
description	9.	Nair, Trilokraj P. "Polymorphisms of the IL12B and IL23R Genes Are Associated with Psoriasis." The Journal of investigative dermatology 128.7 (2007): 1653-61.
description	10.	Blain, Jeffrey A A. "Factor VII deficiency and developmental abnormalities in a patient with partial monosomy of 13q and trisomy of 16p: case report and review of the literature." BMC medical genetics (2006): 2-.
description	11.	Lowes, Michelle A A. "Pathogenesis and therapy of psoriasis." Nature 445.7130 (2007): 866-873.
description	12.	Estivill, X. "Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis." Nature genetics 41.2 (2008): 211-5.
description	13.	Sulli, A. "Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover?" Expert review of clinical immunology 7.4 (2011): 395-7.
description	14.	Daikeler, T. "Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party." Blood 118.6 (2011): 1693-1698.
description	15.	Servettaz, A. "Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the Mouse." The journal of immunology 182.9 (2009): 5855-5864.
description	16.	Abraham, David J J. "Scleroderma: from cell and molecular mechanisms to disease models." Trends in immunology 26.11: 587-595.
description	17.	Berger, Emily M M. "Developments in systemic immunomodulatory therapy for psoriasis." Current opinion in pharmacology 7.4 (2007): 434-444.
description	18.	Lebwohl, M. "Psoriasis." The lancet 361.9364 (2003): 1197-1204.
description	19.	Sch, Michael P P. "Psoriasis." The New England journal of medicine 352.18 (2005): 1899-1912.
description	20.	Griffiths, Christopher E M E. "Pathogenesis and clinical features of psoriasis." The lancet 370.9583 (2007): 263-271.